EXENS Exosens

When the U.S. Treasury 10 year yield pushes above the S&P 500 earnings yield for the first time in 25 years, investors are reminded that dependable power for AI data centers does not only mean computing chips. It also means reliable electricity. That is where long term, carbon free energy suppliers linked to the AI buildout can matter. This article walks through three stocks that sit squarely in that theme. The three companies below are just a first look. The full Nuclear Renaissance screen...

Geopolitical risk in Europe has moved from background noise to front page, with Danish intelligence now flagging the possibility of a limited Russian strike on a NATO state within months. That kind of warning can jolt capital out of some areas and into others very quickly. This article walks through three stocks exposed to this news, all drawn from our Western Defense and Security Stocks screener, and explores how investors might think about them now. The three stocks below are just a...

Exosens (ENXTPA:EXENS) lifted its full-year 2026 earnings guidance, with projected revenue now at €558 million to €570 million, reflecting stronger capacity ramp-up, firm demand in mission-critical imaging and nuclear instrumentation. Exosens shares have reacted to the guidance upgrade, with a 2.97% 1-day share price return and 10.68% 7-day share price return, while the 1-year total shareholder return of 41.70% points to firm momentum despite a modest 1.30% decline over the past month. Scan...